U.S. flag

An official website of the United States government

Format
Items per page
Sort by
Choose Destination

Links from MedGen

Items: 1 to 100 of 825

VariationLocationGene(s)Protein changeCondition(s)Clinical significance
(Last reviewed)
Review status
1.
GRCh37:
Chr17:7577537-7577538
GRCh38:
Chr17:7674219-7674220
TP53Li-Fraumeni syndrome 1Pathogenic
(Mar 10, 2023)
criteria provided, single submitter
2.
GRCh37:
Chr17:7579368-7579369
GRCh38:
Chr17:7676050-7676051
TP53Y107fs, Y68fsLi-Fraumeni syndrome 1Likely pathogenic
(Apr 29, 2023)
criteria provided, single submitter
3.
GRCh37:
Chr17:7579396
GRCh38:
Chr17:7676078
TP53Li-Fraumeni syndrome 1Uncertain significance
(Apr 12, 2023)
criteria provided, single submitter
4.
GRCh37:
Chr17:7577497
GRCh38:
Chr17:7674179
TP53Li-Fraumeni syndrome 1Likely pathogenic
(Jan 12, 2023)
criteria provided, single submitter
5.
GRCh37:
Chr17:7572932-7572933
GRCh38:
Chr17:7669614-7669615
TP53D234fs, D261fs, D354fs, D393fsLi-Fraumeni syndrome 1Uncertain significance
(Jan 31, 2023)
criteria provided, single submitter
6.
GRCh37:
Chr17:7579601
GRCh38:
Chr17:7676283
TP53Li-Fraumeni syndrome 1not providedno assertion provided
7.
GRCh37:
Chr17:7578402
GRCh38:
Chr17:7675084
TP53C17*, C44*, C137*, C176*Hereditary cancer-predisposing syndrome, Li-Fraumeni syndrome 1Pathogenic
(Jul 1, 2023)
criteria provided, multiple submitters, no conflicts
8.
GRCh37:
Chr17:7577494
GRCh38:
Chr17:7674176
TP53Li-Fraumeni syndrome 1Uncertain significance
(Aug 8, 2022)
criteria provided, single submitter
9.
GRCh37:
Chr17:7578531-7578532
GRCh38:
Chr17:7675213-7675214
TP53M133fs, M1fs, M94fsLi-Fraumeni syndrome 1Likely pathogenic
(Jan 27, 2022)
criteria provided, single submitter
10.
GRCh37:
Chr17:7579533
GRCh38:
Chr17:7676215
TP53Q52*, Q13*Hereditary cancer-predisposing syndrome, Li-Fraumeni syndrome, Li-Fraumeni syndrome 1
Pathogenic
(Jun 18, 2022)
criteria provided, multiple submitters, no conflicts
11.
GRCh37:
Chr17:7578204
GRCh38:
Chr17:7674886
TP53S176fs, S215fs, S56fs, S83fsHereditary cancer-predisposing syndrome, Li-Fraumeni syndrome, Li-Fraumeni syndrome 1
Pathogenic
(Jun 18, 2022)
criteria provided, multiple submitters, no conflicts
12.
GRCh37:
Chr17:7577507
GRCh38:
Chr17:7674189
TP53E99D, E126D, E219D, E258DLi-Fraumeni syndrome 1, Li-Fraumeni syndromeUncertain significance
(Jun 1, 2023)
criteria provided, multiple submitters, no conflicts
13.
GRCh37:
Chr17:7579840-7579841
GRCh38:
Chr17:7676522-7676523
TP53L25fsAdrenocortical carcinoma, hereditary, Basal cell carcinoma, susceptibility to, 7, Colorectal cancer,
Li-Fraumeni syndrome 1, Choroid plexus papilloma, Bone marrow failure syndrome 5,
Glioma susceptibility 1
Pathogeniccriteria provided, single submitter
14.
GRCh37:
Chr17:7578514
GRCh38:
Chr17:7675196
TP53K100T, K139T, K7Tnot specified, Hereditary cancer-predisposing syndrome, Li-Fraumeni syndrome 1,
Li-Fraumeni syndrome
Uncertain significance
(Jun 18, 2022)
criteria provided, multiple submitters, no conflicts
15.
GRCh37:
Chr17:7578553-7578565
GRCh38:
Chr17:7675235-7675247
TP53Li-Fraumeni syndrome 1Likely pathogenic
(Feb 11, 2021)
criteria provided, single submitter
16.
GRCh37:
Chr17:7578129
GRCh38:
Chr17:7674811
TP53Hereditary cancer-predisposing syndrome, Li-Fraumeni syndrome 1, not provided,
Li-Fraumeni syndrome
Likely benign
(Jun 18, 2022)
criteria provided, multiple submitters, no conflicts
17.
GRCh37:
Chr17:7579352
GRCh38:
Chr17:7676034
TP53G112D, G73DLi-Fraumeni syndrome 1, not provided, Li-Fraumeni syndrome,
Hereditary cancer-predisposing syndrome
Uncertain significance
(Jun 18, 2022)
criteria provided, multiple submitters, no conflicts
18.
GRCh37:
Chr17:7577533
GRCh38:
Chr17:7674215
TP53P118S, P211S, P250S, P91SLi-Fraumeni syndrome, Li-Fraumeni syndrome 1, not provided,
Hereditary cancer-predisposing syndrome
Uncertain significance
(Jun 18, 2022)
criteria provided, multiple submitters, no conflicts
19.
GRCh37:
Chr17:7577594
GRCh38:
Chr17:7674276
TP53Hereditary cancer-predisposing syndrome, Li-Fraumeni syndrome, Li-Fraumeni syndrome 1,
not provided
Likely benign
(Jun 18, 2022)
criteria provided, multiple submitters, no conflicts
20.
GRCh37:
Chr17:7576501
GRCh38:
Chr17:7673183
TP53Li-Fraumeni syndrome 1, Hereditary breast ovarian cancer syndrome, not provided,
Hereditary cancer-predisposing syndrome
Benign
(Jun 18, 2022)
criteria provided, multiple submitters, no conflicts
21.
GRCh37:
Chr17:7577407
GRCh38:
Chr17:7674089
TP53Li-Fraumeni syndrome 1, Hereditary breast ovarian cancer syndrome, not provided,
Hereditary cancer-predisposing syndrome
Benign
(Jun 18, 2022)
criteria provided, multiple submitters, no conflicts
22.
GRCh37:
Chr17:7577427
GRCh38:
Chr17:7674109
TP53not provided, Hereditary cancer-predisposing syndrome, Li-Fraumeni syndrome 1,
Hereditary breast ovarian cancer syndrome
Benign
(Jun 18, 2022)
criteria provided, multiple submitters, no conflicts
23.
GRCh37:
Chr17:7577085-7577111
GRCh38:
Chr17:7673767-7673793
TP53Li-Fraumeni syndrome 1Likely pathogenic
(Aug 24, 2021)
criteria provided, single submitter
24.
GRCh37:
Chr17:7578129
GRCh38:
Chr17:7674811
TP53Hereditary cancer-predisposing syndrome, Li-Fraumeni syndrome 1, not specified,
not provided
Benign/Likely benign
(Aug 15, 2023)
criteria provided, multiple submitters, no conflicts
25.
GRCh37:
Chr17:7578291
GRCh38:
Chr17:7674973
TP53Hereditary cancer-predisposing syndrome, not provided, Li-Fraumeni syndrome,
Li-Fraumeni syndrome 1
Pathogenic
(Nov 8, 2022)
criteria provided, multiple submitters, no conflicts
26.
GRCh37:
Chr17:7579867
GRCh38:
Chr17:7676549
TP53Q16KLi-Fraumeni syndrome 1Uncertain significance
(Jun 16, 2021)
reviewed by expert panel
FDA Recognized Database
27.
GRCh37:
Chr17:7577072
GRCh38:
Chr17:7673754
TP53L130P, L157P, L250P, L289PLi-Fraumeni syndrome 1Likely benign
(Jun 16, 2021)
reviewed by expert panel
FDA Recognized Database
28.
GRCh37:
Chr17:7578399
GRCh38:
Chr17:7675081
TP53Li-Fraumeni syndrome, Hereditary cancer-predisposing syndrome, Li-Fraumeni syndrome 1
Likely benign
(Jun 18, 2022)
criteria provided, multiple submitters, no conflicts
29.
GRCh37:
Chr17:7571487-7571488
GRCh38:
Chr17:7668169-7668170
TP53Li-Fraumeni syndrome, Hereditary cancer-predisposing syndrome, not provided,
Li-Fraumeni syndrome 1
Benign
(Nov 4, 2022)
criteria provided, multiple submitters, no conflicts
30.
GRCh37:
Chr17:7577582
GRCh38:
Chr17:7674264
TP53Li-Fraumeni syndrome 1, Hereditary cancer-predisposing syndrome, Li-Fraumeni syndrome
Likely benign
(Oct 22, 2022)
criteria provided, multiple submitters, no conflicts
31.
GRCh37:
Chr17:7579498
GRCh38:
Chr17:7676180
TP53Li-Fraumeni syndrome 1, Hereditary cancer-predisposing syndrome, Li-Fraumeni syndrome
Likely benign
(Jun 18, 2022)
criteria provided, multiple submitters, no conflicts
32.
GRCh37:
Chr17:7574018
GRCh38:
Chr17:7670700
TP53R178S, R205S, R298S, R337SLi-Fraumeni syndrome 1Uncertain significance
(Jun 3, 2021)
reviewed by expert panel
FDA Recognized Database
33.
GRCh37:
Chr17:7577113
GRCh38:
Chr17:7673795
TP53C116*, C143*, C236*, C275*Li-Fraumeni syndrome 1Pathogenic
(Apr 2, 2020)
criteria provided, single submitter
34.
GRCh37:
Chr17:7579922
GRCh38:
Chr17:7676604
TP53not provided, Hereditary cancer-predisposing syndrome, Li-Fraumeni syndrome 1
Uncertain significance
(Jun 18, 2022)
criteria provided, multiple submitters, no conflicts
35.
GRCh37:
Chr17:7577046
GRCh38:
Chr17:7673728
TP53E139fs, E166fs, E259fs, E298fsnot provided, Hereditary cancer-predisposing syndrome, Li-Fraumeni syndrome,
Li-Fraumeni syndrome 1
Pathogenic/Likely pathogenic
(Jun 18, 2022)
criteria provided, multiple submitters, no conflicts
36.
GRCh37:
Chr17:7572980
GRCh38:
Chr17:7669662
TP53T218P, T245P, T338P, T377PLi-Fraumeni syndrome 1Uncertain significance
(Mar 6, 2018)
criteria provided, single submitter
37.
GRCh37:
Chr17:7578443-7578448
GRCh38:
Chr17:7675125-7675130
TP53Li-Fraumeni syndrome 1Uncertain significance
(Mar 14, 2022)
reviewed by expert panel
FDA Recognized Database
38.
GRCh37:
Chr17:7577604
GRCh38:
Chr17:7674286
TP53G187A, G94A, G67A, G226ALi-Fraumeni syndrome, Adrenocortical carcinoma, hereditary, Familial cancer of breast,
Glioma susceptibility 1, Li-Fraumeni syndrome 1, Nasopharyngeal carcinoma,
Carcinoma of pancreas, Choroid plexus papilloma, Bone osteosarcoma,
Basal cell carcinoma, susceptibility to, 7, Hepatocellular carcinomaColorectal cancer,
Bone marrow failure syndrome 5, ...see more
Uncertain significance
(Nov 29, 2021)
criteria provided, multiple submitters, no conflicts
39.
GRCh37:
Chr17:7578475-7578477
GRCh38:
Chr17:7675157-7675159
TP53P114del, P153del, P21delHereditary cancer-predisposing syndrome, Li-Fraumeni syndrome, Li-Fraumeni syndrome 1
Uncertain significance
(Jun 18, 2022)
criteria provided, multiple submitters, no conflicts
40.
GRCh37:
Chr17:7576929-7576940
GRCh38:
Chr17:7673611-7673622
TP53Hereditary cancer-predisposing syndrome, Li-Fraumeni syndrome, Li-Fraumeni syndrome 1
Conflicting interpretations of pathogenicity
(Sep 15, 2022)
criteria provided, conflicting interpretations
41.
GRCh37:
Chr17:7578169-7578171
GRCh38:
Chr17:7674851-7674853
TP53Hereditary cancer-predisposing syndrome, Breast and/or ovarian cancer, Li-Fraumeni syndrome 1
Uncertain significance
(Jun 18, 2022)
criteria provided, multiple submitters, no conflicts
42.
GRCh37:
Chr17:7579908
GRCh38:
Chr17:7676590
TP53E2GLi-Fraumeni syndrome, Li-Fraumeni syndrome 1, Hereditary cancer-predisposing syndrome
Uncertain significance
(Jun 18, 2022)
criteria provided, multiple submitters, no conflicts
43.
GRCh37:
Chr17:7577597
GRCh38:
Chr17:7674279
TP53D189E, D228E, D69E, D96ELi-Fraumeni syndrome, Li-Fraumeni syndrome 1, Hereditary cancer-predisposing syndrome
Conflicting interpretations of pathogenicity
(Jun 18, 2022)
criteria provided, conflicting interpretations
44.
GRCh37:
Chr17:7577047
GRCh38:
Chr17:7673729
TP53H258Q, H297Q, H138Q, H165QLi-Fraumeni syndrome 1, Hereditary cancer-predisposing syndromeUncertain significance
(Jun 18, 2022)
criteria provided, multiple submitters, no conflicts
45.
GRCh37:
Chr17:7577100
GRCh38:
Chr17:7673782
TP53Hereditary cancer-predisposing syndrome, Li-Fraumeni syndrome, Li-Fraumeni syndrome 1
Likely benign
(Oct 14, 2022)
criteria provided, multiple submitters, no conflicts
46.
GRCh37:
Chr17:7578273
GRCh38:
Chr17:7674955
TP53Q60H, Q33H, Q153H, Q192HHereditary cancer-predisposing syndrome, Li-Fraumeni syndrome 1, Li-Fraumeni syndrome
Uncertain significance
(Jun 18, 2022)
criteria provided, multiple submitters, no conflicts
47.
GRCh37:
Chr17:7577589
GRCh38:
Chr17:7674271
TP53T99S, T72S, T192S, T231SLi-Fraumeni syndrome 1, Hereditary cancer-predisposing syndrome, Li-Fraumeni syndrome
Uncertain significance
(Jun 18, 2022)
criteria provided, multiple submitters, no conflicts
48.
GRCh37:
Chr17:7577169
GRCh38:
Chr17:7673851
TP53Hereditary cancer-predisposing syndrome, Li-Fraumeni syndrome 1, Li-Fraumeni syndrome
Likely benign
(Oct 18, 2022)
criteria provided, multiple submitters, no conflicts
49.
GRCh37:
Chr17:7578568
GRCh38:
Chr17:7675250
TP53Hereditary cancer-predisposing syndrome, Li-Fraumeni syndrome, Li-Fraumeni syndrome 1
Likely benign
(Jun 18, 2022)
criteria provided, multiple submitters, no conflicts
50.
GRCh37:
Chr17:7578423
GRCh38:
Chr17:7675105
TP53M130I, M169I, M10I, M37IHereditary cancer-predisposing syndrome, Li-Fraumeni syndrome, Li-Fraumeni syndrome 1
Uncertain significance
(Jun 18, 2022)
criteria provided, multiple submitters, no conflicts
51.
GRCh37:
Chr17:7573007
GRCh38:
Chr17:7669689
TP53H329N, H209N, H368N, H236NHereditary cancer-predisposing syndrome, Li-Fraumeni syndrome, Li-Fraumeni syndrome 1
Uncertain significance
(Jun 18, 2022)
criteria provided, multiple submitters, no conflicts
52.
GRCh37:
Chr17:7579468
GRCh38:
Chr17:7676150
TP53Li-Fraumeni syndrome, Hereditary cancer-predisposing syndrome, Li-Fraumeni syndrome 1
Likely benign
(Jun 18, 2022)
criteria provided, multiple submitters, no conflicts
53.
GRCh37:
Chr17:7572783
GRCh38:
Chr17:7669465
TP53Li-Fraumeni syndrome 1Uncertain significance
(Apr 28, 2017)
criteria provided, single submitter
54.
GRCh37:
Chr17:7590789
GRCh38:
Chr17:7687471
LOC126862483, TP53, WRAP53Li-Fraumeni syndrome 1Uncertain significance
(Mar 30, 2018)
criteria provided, single submitter
55.
GRCh37:
Chr17:7572759
GRCh38:
Chr17:7669441
TP53Li-Fraumeni syndrome 1Uncertain significance
(Jan 12, 2018)
criteria provided, single submitter
56.
GRCh37:
Chr17:7572599
GRCh38:
Chr17:7669281
TP53Li-Fraumeni syndrome 1Benign
(Mar 6, 2018)
criteria provided, single submitter
57.
GRCh37:
Chr17:7572570
GRCh38:
Chr17:7669252
TP53Li-Fraumeni syndrome 1Likely benign
(Jan 13, 2018)
criteria provided, single submitter
58.
GRCh37:
Chr17:7572518
GRCh38:
Chr17:7669200
TP53Li-Fraumeni syndrome 1Likely benign
(Jan 13, 2018)
criteria provided, single submitter
59.
GRCh37:
Chr17:7579934
GRCh38:
Chr17:7676616
TP53Li-Fraumeni syndrome 1Uncertain significance
(Apr 27, 2017)
criteria provided, single submitter
60.
GRCh37:
Chr17:7572167
GRCh38:
Chr17:7668849
TP53Li-Fraumeni syndrome 1Uncertain significance
(Jan 13, 2018)
criteria provided, single submitter
61.
GRCh37:
Chr17:7572166
GRCh38:
Chr17:7668848
TP53Li-Fraumeni syndrome 1Uncertain significance
(Apr 27, 2017)
criteria provided, single submitter
62.
GRCh37:
Chr17:7571795
GRCh38:
Chr17:7668477
TP53Li-Fraumeni syndrome 1, not providedConflicting interpretations of pathogenicity
(May 1, 2023)
criteria provided, conflicting interpretations
63.
GRCh37:
Chr17:7577161
GRCh38:
Chr17:7673843
TP53Li-Fraumeni syndrome, Li-Fraumeni syndrome 1Uncertain significance
(Aug 8, 2022)
criteria provided, multiple submitters, no conflicts
64.
GRCh37:
Chr17:7579906
GRCh38:
Chr17:7676588
TP53E3KHereditary cancer-predisposing syndrome, Li-Fraumeni syndrome, Li-Fraumeni syndrome 1
Conflicting interpretations of pathogenicity
(Jun 18, 2022)
criteria provided, conflicting interpretations
65.
GRCh37:
Chr17:7579710
GRCh38:
Chr17:7676392
TP53N29TLi-Fraumeni syndrome, Hereditary cancer-predisposing syndrome, Li-Fraumeni syndrome 1
Uncertain significance
(May 23, 2023)
criteria provided, multiple submitters, no conflicts
66.
GRCh37:
Chr17:7577018-7577019
GRCh38:
Chr17:7673700-7673701
TP53Li-Fraumeni syndrome, Li-Fraumeni syndrome 1, Hereditary cancer-predisposing syndrome
Pathogenic/Likely pathogenic
(Jun 18, 2022)
criteria provided, multiple submitters, no conflicts
67.
GRCh37:
Chr17:7577112
GRCh38:
Chr17:7673794
TP53A117T, A276T, A144T, A237TLi-Fraumeni syndrome 1, Li-Fraumeni syndrome, Hereditary cancer-predisposing syndrome
Uncertain significance
(Jun 18, 2022)
criteria provided, multiple submitters, no conflicts
68.
GRCh37:
Chr17:7577137
GRCh38:
Chr17:7673819
TP53Li-Fraumeni syndrome 1, Hereditary cancer-predisposing syndrome, Li-Fraumeni syndrome
Likely benign
(Jun 18, 2022)
criteria provided, multiple submitters, no conflicts
69.
GRCh37:
Chr17:7577512
GRCh38:
Chr17:7674194
TP53L218V, L98V, L257V, L125VLi-Fraumeni syndrome 1, Hereditary cancer-predisposing syndrome, Li-Fraumeni syndrome
Uncertain significance
(Jun 18, 2022)
criteria provided, multiple submitters, no conflicts
70.
GRCh37:
Chr17:7578201
GRCh38:
Chr17:7674883
TP53Hereditary cancer-predisposing syndrome, Li-Fraumeni syndrome 1, Li-Fraumeni syndrome,
Squamous cell carcinoma of the head and neck
Benign/Likely benign
(Jul 2, 2022)
criteria provided, multiple submitters, no conflicts
71.
GRCh37:
Chr17:7578206-7578207
GRCh38:
Chr17:7674888-7674889
TP53H214fs, H55fs, H82fs, H175fsnot provided, Li-Fraumeni syndrome 1, Hereditary cancer-predisposing syndrome,
Li-Fraumeni syndrome
Pathogenic
(Apr 5, 2023)
criteria provided, multiple submitters, no conflicts
72.
GRCh37:
Chr17:7578212
GRCh38:
Chr17:7674894
TP53Li-Fraumeni syndrome 1, Hereditary cancer-predisposing syndrome, Li-Fraumeni syndrome
Likely benign
(Jun 18, 2022)
criteria provided, multiple submitters, no conflicts
73.
GRCh37:
Chr17:7578216
GRCh38:
Chr17:7674898
TP53Li-Fraumeni syndrome 1, Hereditary cancer-predisposing syndrome, Li-Fraumeni syndrome
Likely benign
(Jun 18, 2022)
criteria provided, multiple submitters, no conflicts
74.
GRCh37:
Chr17:7578227
GRCh38:
Chr17:7674909
TP53D208H, D49H, D169H, D76HLi-Fraumeni syndrome 1, Hereditary cancer-predisposing syndrome, Li-Fraumeni syndrome
Uncertain significance
(Jun 18, 2022)
criteria provided, multiple submitters, no conflicts
75.
GRCh37:
Chr17:7579854
GRCh38:
Chr17:7676536
TP53S20LHereditary cancer-predisposing syndrome, Li-Fraumeni syndrome 1, Li-Fraumeni syndrome
Uncertain significance
(Jun 18, 2022)
criteria provided, multiple submitters, no conflicts
76.
GRCh37:
Chr17:7578259
GRCh38:
Chr17:7674941
TP53V197G, V38G, V158G, V65GHereditary cancer-predisposing syndrome, Li-Fraumeni syndrome 1, Li-Fraumeni syndrome
Uncertain significance
(Sep 21, 2022)
criteria provided, multiple submitters, no conflicts
77.
GRCh37:
Chr17:7578286
GRCh38:
Chr17:7674968
TP53L149fs, L56fs, L188fs, L29fsLi-Fraumeni syndrome 1, Hereditary cancer-predisposing syndrome, Li-Fraumeni syndrome
Pathogenic
(Jun 18, 2022)
criteria provided, multiple submitters, no conflicts
78.
GRCh37:
Chr17:7578388
GRCh38:
Chr17:7675070
TP53R181P, R22P, R142P, R49PHereditary cancer-predisposing syndrome, Li-Fraumeni syndrome 1, Li-Fraumeni syndrome
Pathogenic/Likely pathogenic
(Jun 18, 2022)
criteria provided, multiple submitters, no conflicts
79.
GRCh37:
Chr17:7578399
GRCh38:
Chr17:7675081
TP53Hereditary cancer-predisposing syndrome, Li-Fraumeni syndrome 1, Li-Fraumeni syndrome
Likely benign
(Jul 22, 2022)
criteria provided, multiple submitters, no conflicts
80.
GRCh37:
Chr17:7578420
GRCh38:
Chr17:7675102
TP53Hereditary cancer-predisposing syndrome, Li-Fraumeni syndrome 1, Li-Fraumeni syndrome
Likely benign
(Jun 18, 2022)
criteria provided, multiple submitters, no conflicts
81.
GRCh37:
Chr17:7578475
GRCh38:
Chr17:7675157
TP53P152R, P20R, P113RHereditary cancer-predisposing syndrome, Li-Fraumeni syndrome 1, Li-Fraumeni syndrome
Pathogenic/Likely pathogenic
(Jul 15, 2022)
criteria provided, multiple submitters, no conflicts
82.
GRCh37:
Chr17:7578492
GRCh38:
Chr17:7675174
TP53W146C, W107C, W14CHereditary cancer-predisposing syndrome, Li-Fraumeni syndrome 1, Li-Fraumeni syndrome
Uncertain significance
(Jun 18, 2022)
criteria provided, multiple submitters, no conflicts
83.
GRCh37:
Chr17:7579871
GRCh38:
Chr17:7676553
TP53Hereditary cancer-predisposing syndrome, Li-Fraumeni syndrome 1, Li-Fraumeni syndrome
Likely benign
(Jun 18, 2022)
criteria provided, multiple submitters, no conflicts
84.
GRCh37:
Chr17:7578504-7578540
GRCh38:
Chr17:7675186-7675222
TP53N131fs, M1fs, N92fsHereditary cancer-predisposing syndrome, Li-Fraumeni syndrome 1, Li-Fraumeni syndrome,
Familial cancer of breast
Pathogenic
(Jun 18, 2022)
criteria provided, multiple submitters, no conflicts
85.
GRCh37:
Chr17:7578547
GRCh38:
Chr17:7675229
TP53P128L, P89LHereditary cancer-predisposing syndrome, Li-Fraumeni syndrome 1, Li-Fraumeni syndrome
Uncertain significance
(Oct 13, 2022)
criteria provided, multiple submitters, no conflicts
86.
GRCh37:
Chr17:7578551
GRCh38:
Chr17:7675233
TP53S127T, S88THereditary cancer-predisposing syndrome, Li-Fraumeni syndrome 1, Li-Fraumeni syndrome
Conflicting interpretations of pathogenicity
(Jun 18, 2022)
criteria provided, conflicting interpretations
87.
GRCh37:
Chr17:7579349
GRCh38:
Chr17:7676031
TP53F74S, F113SHereditary cancer-predisposing syndrome, Li-Fraumeni syndrome 1Uncertain significance
(May 28, 2022)
criteria provided, multiple submitters, no conflicts
88.
GRCh37:
Chr17:7576855
GRCh38:
Chr17:7673537
TP53Q292K, Q172K, Q199K, Q331KHereditary cancer-predisposing syndrome, Li-Fraumeni syndrome 1, Li-Fraumeni syndrome
Uncertain significance
(Jun 18, 2022)
criteria provided, multiple submitters, no conflicts
89.
GRCh37:
Chr17:7576900
GRCh38:
Chr17:7673582
TP53P277S, P157S, P316S, P184SHereditary cancer-predisposing syndrome, Li-Fraumeni syndrome 1, Li-Fraumeni syndrome
Conflicting interpretations of pathogenicity
(Sep 9, 2022)
criteria provided, conflicting interpretations
90.
GRCh37:
Chr17:7576930
GRCh38:
Chr17:7673612
TP53Li-Fraumeni syndrome, Hereditary cancer-predisposing syndrome, Li-Fraumeni syndrome 1
Likely benign
(Jun 18, 2022)
criteria provided, multiple submitters, no conflicts
91.
GRCh37:
Chr17:7579378
GRCh38:
Chr17:7676060
TP53Y103*, Y64*Hereditary cancer-predisposing syndrome, Li-Fraumeni syndrome 1, Li-Fraumeni syndrome
Pathogenic
(Jun 18, 2022)
criteria provided, multiple submitters, no conflicts
92.
GRCh37:
Chr17:7579884
GRCh38:
Chr17:7676566
TP53V10GLi-Fraumeni syndrome 1, Li-Fraumeni syndrome, Hereditary cancer-predisposing syndrome
Uncertain significance
(Jun 18, 2022)
criteria provided, multiple submitters, no conflicts
93.
GRCh37:
Chr17:7572979
GRCh38:
Chr17:7669661
TP53T377I, T218I, T245I, T338ILi-Fraumeni syndrome 1, Hereditary cancer-predisposing syndrome, Li-Fraumeni syndrome
Conflicting interpretations of pathogenicity
(Oct 13, 2022)
criteria provided, conflicting interpretations
94.
GRCh37:
Chr17:7573974
GRCh38:
Chr17:7670656
TP53K351N, K219N, K312N, K192NLi-Fraumeni syndrome 1, Hereditary cancer-predisposing syndrome, Li-Fraumeni syndrome
Uncertain significance
(Jun 18, 2022)
criteria provided, multiple submitters, no conflicts
95.
GRCh37:
Chr17:7574011
GRCh38:
Chr17:7670693
TP53E300G, E180G, E207G, E339Gnot provided, Li-Fraumeni syndrome 1, Hereditary cancer-predisposing syndrome,
Li-Fraumeni syndrome
Uncertain significance
(Jun 18, 2022)
criteria provided, multiple submitters, no conflicts
96.
GRCh37:
Chr17:7579886
GRCh38:
Chr17:7676568
TP53S9RHereditary cancer-predisposing syndrome, Li-Fraumeni syndrome 1Uncertain significance
(Jun 18, 2022)
criteria provided, multiple submitters, no conflicts
97.
GRCh37:
Chr17:7579504
GRCh38:
Chr17:7676186
TP53D22E, D61EHereditary cancer-predisposing syndrome, Li-Fraumeni syndrome, Li-Fraumeni syndrome 1
Conflicting interpretations of pathogenicity
(Apr 27, 2023)
criteria provided, conflicting interpretations
98.
GRCh37:
Chr17:7572932
GRCh38:
Chr17:7669614
TP53D234H, D261H, D354H, D393HLi-Fraumeni syndrome 1, Li-Fraumeni syndrome, Hereditary cancer-predisposing syndrome
Conflicting interpretations of pathogenicity
(Jun 18, 2022)
criteria provided, conflicting interpretations
99.
GRCh37:
Chr17:7579580
GRCh38:
Chr17:7676262
TP53P36LLi-Fraumeni syndrome, Li-Fraumeni syndrome 1, Hereditary cancer-predisposing syndrome
Uncertain significance
(Jul 11, 2022)
criteria provided, multiple submitters, no conflicts
100.
GRCh37:
Chr17:7573997
GRCh38:
Chr17:7670679
TP53Li-Fraumeni syndrome 1, Li-Fraumeni syndrome, Hereditary cancer-predisposing syndrome
Likely benign
(Aug 19, 2022)
criteria provided, multiple submitters, no conflicts
Format
Items per page
Sort by
Choose Destination